Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts

Transplant Proc. 1997 Feb-Mar;29(1-2):333. doi: 10.1016/s0041-1345(96)00290-4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arteriosclerosis / pathology
  • Arteriosclerosis / physiopathology
  • Chemokine CCL2 / biosynthesis
  • Chemokine CCL5 / biosynthesis
  • Chronic Disease
  • Cyclosporine / therapeutic use*
  • Cytokines / biosynthesis
  • Graft Rejection / prevention & control*
  • Graft Survival
  • Heart Transplantation / immunology*
  • Heart Transplantation / pathology
  • Humans
  • Immunization
  • Immunosuppressive Agents / therapeutic use*
  • Polyenes / therapeutic use*
  • Postoperative Complications
  • Sirolimus
  • Transcription, Genetic
  • Transplantation, Homologous

Substances

  • Chemokine CCL2
  • Chemokine CCL5
  • Cytokines
  • Immunosuppressive Agents
  • Polyenes
  • Cyclosporine
  • Sirolimus